Skip to main content
. 2020 Aug 26;11(2):560–571. doi: 10.1016/j.apsb.2020.08.012

Figure 3.

Figure 3

The degradation and drug release profiles of HPMPC and RPMPC nanogels. (A) The relative turbidity change of HPMPC nanogel with air, 5% of oxygen and 1% of oxygen gas flow. (B) The relative turbidity change of RPMPC nanogel with 0, 5 and 10 m mmol/L GSH. (C) Gel permeation chromatography (GPC) trace of the products of HPMPC and RPMPC nanogels after degradation. (D) Doxorubicin (DOX) release profiles of HPMPC@DOX with air and 1% of oxygen gas flow or RPMPC@DOX with 0 and 10 m mmol/L GSH at 37 °C in phosphate buffer.